id: NEW:transoral_robotic_surgery_salvage_to_NEW:head_neck_cancer_survival
name: Transoral Robotic Surgery for Salvage Treatment â†’ Head and Neck Cancer Survival
  Outcomes
from_node:
  node_id: NEW:transoral_robotic_surgery_salvage
  node_name: Transoral Robotic Surgery for Salvage Treatment
to_node:
  node_id: NEW:head_neck_cancer_survival
  node_name: Head and Neck Cancer Survival Outcomes
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Patients with residual, recurrent, or second primary head and neck cancers
  in previously irradiated fields receive transoral robotic surgery (TORS) as a salvage
  treatment option'
- 'Step 2: TORS provides minimally invasive surgical access to tumors, enabling curative
  intent resection while minimizing surgical morbidity compared to traditional open
  techniques'
- 'Step 3: Reduced surgical trauma leads to shorter hospital stays (mean 8.5 days),
  faster tracheostomy decannulation (9.7 days), and lower rates of long-term functional
  dependence'
- 'Step 4: The technique achieves acceptable oncological control with 2-year overall
  survival rate of 73.8% and disease-free survival rate of 56.1% in this challenging
  salvage population'
- 'Step 5: Lower complication rates (32.3% pooled, with 92% being Clavien Dindo grade
  2-3) and reduced morbidity contribute to better overall survival outcomes compared
  to traditional open surgical approaches'
evidence:
  quality_rating: A
  n_studies: 15
  primary_citation: 'Sahil Goel et al. 2025. Is transoral robotic surgery useful as
    a salvage technique in head and neck cancers: a systematic review and meta analysis.
    Head & neck.'
  supporting_citations: []
description: Transoral robotic surgery (TORS) provides an effective salvage treatment
  option for patients with residual, recurrent, or second primary head and neck cancers
  in previously irradiated fields. This systematic review and meta-analysis of 15
  studies (515 patients) demonstrates that TORS achieves 2-year overall survival of
  73.8% and disease-free survival of 56.1%, with decreased morbidity and mortality
  compared to traditional open surgical techniques. The minimally invasive approach
  enables curative intent surgery with acceptable functional outcomes and complication
  rates.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.35
    type: relative_risk
    ci_lower: 0.18
    ci_upper: 0.67
  p_value: null
  sample_size: 515
moderators:
- name: HPV status
  direction: strengthens
  strength: moderate
  description: Authors note HPV status as a confounding factor requiring future study;
    HPV-positive tumors generally have better prognosis
- name: Prior adjuvant therapy
  direction: weakens
  strength: moderate
  description: Prior radiation therapy affects tissue quality and surgical outcomes;
    identified as confounding factor
- name: Surgical margin status
  direction: weakens
  strength: moderate
  description: Positive surgical margins occurred in 19.4% of cases, associated with
    higher recurrence risk (36% recurrence rate)
